Winslow Evans & Crocker’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$8K Buy
640
+315
+97% +$4.34K ﹤0.01% 988
2020
Q3
$5K Hold
325
﹤0.01% 873
2020
Q2
$5K Sell
325
-1
-0.3% -$13 ﹤0.01% 874
2020
Q1
$4K Buy
+326
New +$2.56K ﹤0.01% 883

Other funds holding CGEN

Winslow Evans & Crocker's CGEN Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Compugen (CGEN) stake by 97% in Q4 2020, buying an estimated $4.34K and bringing the position to 640 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Winslow Evans & Crocker first reported a position in CGEN in Q1 2020 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.

  • Winslow Evans & Crocker held 640 shares of Compugen worth $8K as of Q4 2020.
  • Winslow Evans & Crocker bought 315 Compugen shares in Q4 2020, an estimated $4.34K.
  • Compugen made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #988 holding.
  • Winslow Evans & Crocker first reported a position in Compugen in Q1 2020 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.